Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 5
2005 7
2006 4
2007 6
2008 2
2009 3
2010 3
2011 2
2014 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
The neuroprotective role of creatine.
Klein AM, Ferrante RJ. Klein AM, et al. Subcell Biochem. 2007;46:205-43. doi: 10.1007/978-1-4020-6486-9_11. Subcell Biochem. 2007. PMID: 18652079 Review.
Huntington's disease: progress and potential in the field.
Stack EC, Ferrante RJ. Stack EC, et al. Expert Opin Investig Drugs. 2007 Dec;16(12):1933-53. doi: 10.1517/13543784.16.12.1933. Expert Opin Investig Drugs. 2007. PMID: 18042002 Review.
Emerging chemotherapeutic strategies for Huntington's disease.
Ryu H, Ferrante RJ. Ryu H, et al. Expert Opin Emerg Drugs. 2005 May;10(2):345-63. doi: 10.1517/14728214.10.2.345. Expert Opin Emerg Drugs. 2005. PMID: 15934871 Review.
The therapeutic role of creatine in Huntington's disease.
Ryu H, Rosas HD, Hersch SM, Ferrante RJ. Ryu H, et al. Pharmacol Ther. 2005 Nov;108(2):193-207. doi: 10.1016/j.pharmthera.2005.04.008. Epub 2005 Aug 1. Pharmacol Ther. 2005. PMID: 16055197 Review.
Mouse models of Huntington's disease and methodological considerations for therapeutic trials.
Ferrante RJ. Ferrante RJ. Biochim Biophys Acta. 2009 Jun;1792(6):506-20. doi: 10.1016/j.bbadis.2009.04.001. Epub 2009 Apr 10. Biochim Biophys Acta. 2009. PMID: 19362590 Free PMC article. Review.
Translating therapies for Huntington's disease from genetic animal models to clinical trials.
Hersch SM, Ferrante RJ. Hersch SM, et al. NeuroRx. 2004 Jul;1(3):298-306. doi: 10.1602/neurorx.1.3.298. NeuroRx. 2004. PMID: 15717031 Free PMC article. Review.
Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.
Stack EC, Matson WR, Ferrante RJ. Stack EC, et al. Ann N Y Acad Sci. 2008 Dec;1147:79-92. doi: 10.1196/annals.1427.008. Ann N Y Acad Sci. 2008. PMID: 19076433 Review.
Experimental models of HD and reflection on therapeutic strategies.
Kim J, Bordiuk OL, Ferrante RJ. Kim J, et al. Int Rev Neurobiol. 2011;98:419-81. doi: 10.1016/B978-0-12-381328-2.00016-X. Int Rev Neurobiol. 2011. PMID: 21907096 Review.
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.
Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ. Kim J, et al. Hum Mol Genet. 2010 Oct 15;19(20):3919-35. doi: 10.1093/hmg/ddq306. Epub 2010 Jul 21. Hum Mol Genet. 2010. PMID: 20660112 Free PMC article.
Modulation of nucleosome dynamics in Huntington's disease.
Stack EC, Del Signore SJ, Luthi-Carter R, Soh BY, Goldstein DR, Matson S, Goodrich S, Markey AL, Cormier K, Hagerty SW, Smith K, Ryu H, Ferrante RJ. Stack EC, et al. Hum Mol Genet. 2007 May 15;16(10):1164-75. doi: 10.1093/hmg/ddm064. Epub 2007 Apr 2. Hum Mol Genet. 2007. PMID: 17403718
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback